Trial Outcomes & Findings for Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis (NCT NCT02083263)

NCT ID: NCT02083263

Last Updated: 2014-07-16

Results Overview

Lung clearance index was calculated as the number of lung volume turnovers (cumulative expired volume divided by the functional residual capacity) required to reduce end-tidal nitrogen concentration to 1/40th of the starting value.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

32 participants

Primary outcome timeframe

up to 3 months

Results posted on

2014-07-16

Participant Flow

Participant milestones

Participant milestones
Measure
Bilevel
Bilevel, 3 months Bilevel: 3 months
PEP Mask
PEP mask, 3 months PEP mask: 3 months
Overall Study
STARTED
16
16
Overall Study
COMPLETED
16
16
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Bilevel
n=16 Participants
Bilevel, 3 months Bilevel: 3 months
PEP Mask
n=16 Participants
PEP mask, 3 months PEP mask: 3 months
Total
n=32 Participants
Total of all reporting groups
Age, Continuous
28 years
STANDARD_DEVIATION 11 • n=5 Participants
33 years
STANDARD_DEVIATION 9 • n=7 Participants
31 years
STANDARD_DEVIATION 10 • n=5 Participants
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
16 Participants
n=5 Participants
16 Participants
n=7 Participants
32 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Sex: Female, Male
Female
8 Participants
n=5 Participants
8 Participants
n=7 Participants
16 Participants
n=5 Participants
Sex: Female, Male
Male
8 Participants
n=5 Participants
8 Participants
n=7 Participants
16 Participants
n=5 Participants
Region of Enrollment
Sweden
16 participants
n=5 Participants
16 participants
n=7 Participants
32 participants
n=5 Participants

PRIMARY outcome

Timeframe: up to 3 months

Lung clearance index was calculated as the number of lung volume turnovers (cumulative expired volume divided by the functional residual capacity) required to reduce end-tidal nitrogen concentration to 1/40th of the starting value.

Outcome measures

Outcome measures
Measure
Bilevel
n=16 Participants
Bilevel, 3 months Bilevel: 3 months
PEP Mask
n=16 Participants
PEP mask, 3 months PEP mask: 3 months
Lung Function: Lung Clearance Index
9 lung clearance index
Standard Deviation 3
9.7 lung clearance index
Standard Deviation 3

SECONDARY outcome

Timeframe: 1 month

After physiotherapy will take blood gases (kpa) before chest physiotherapy and perform once a month.

Outcome measures

Outcome data not reported

Adverse Events

Bilevel

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

PEP Mask

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Maria Cecilia Rodriguez Hortal

Karolinska University Hospital

Phone: 0046709558699

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place